Noradrenergic reuptake inhibition in the treatment of pain

Bibliography

• Leak JA. Herbal medicine: is it an alternative or an unknown? A brief review of popular herbals used by patients in a pain and symptom management practice setting. Curr Rev Pain 1999;3:226-36
   PubMedGoogle Scholar
• Stein C, Machelska H. Modulation of peripheral sensory neurons by the immune system: implications for pain therapy. Pharmacol Rev 2011;63:860-81
   PubMed Web of Science ®Google Scholar
• Jensen TS, Baron R, Haanpää M, A new definition of neuropathic pain. Pain 2011;152(10):2204-5
   PubMed Web of Science ®Google Scholar
• Dell’Osso B, Buoli M, Baldwin DS, Altamura AC. Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy. Hum Psychopharmacol Clin Exp 2010;25:17-29
   PubMed Web of Science ®Google Scholar
• Pergolizzi JV, Raffa RB, Taylor R, A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain. Pain Pract 2012; Epub ahead of print
   Google Scholar
• Hall FS, Scharzbaum JM, Perona MTG, A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception. Neuroscience 2011;175:315-27
   PubMed Web of Science ®Google Scholar
• Rojo ML, Rodríguez-Gaztelumendi A, Pazos A, Díaz A. Differential adaptive changes on serotonin and noradrenaline transporters in a rat model of peripheral neuropathic pain. Neurosci Lett 2012;515:181-6
   PubMed Web of Science ®Google Scholar
• Hayashida K-I, Eisenach JC. Spinal α2-adrenoceptor mediated analgesia in neuropathic pain reflects brain derived nerve growth factor and changes in spinal cholinergic neuronal function. Anesthesiology 2010;113(2):406-12
   PubMed Web of Science ®Google Scholar
• Schroder W, Vry JD, Tzschentke TM, Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic pain. Eur J Pain 2010;14(8):814-21
   PubMed Web of Science ®Google Scholar
• Chaparro LE, Wiffen PJ, Moore RA, Gilron I. Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database of Syst Rev 2012(7):CD008943
   Google Scholar
• Hayashida K, DeGoes S, Curry R, Eisenach JC. Gabapentin activates spinal noradrenergic activity in rats and humans and reduces hypersensitivity after surgery. Anesthesiology 2007;106(3):557-62
   PubMed Web of Science ®Google Scholar
• Schroder W, Tzschentke TM, Terlinden R, Synergistic interaction between the two mechanisms of action of tapentadol in analgesia. J Pharmacol Exp Ther 2011;337(1):312-20
   PubMed Web of Science ®Google Scholar
• Ossipov MH, Dussor GO, Porreca F. Central modulation of pain. J Clin Invest 2010;120(11):3779-87
   PubMed Web of Science ®Google Scholar
• Alba-Delgado C, Borges G, Sánchez-Blázquez P, The function of alpha-2-adrenoceptors in the rat locus coeruleus is preserved in the chronic constriction injury model of neuropathic pain. Psychopharmacology (Berl) 2012;221:53-65
   PubMed Web of Science ®Google Scholar
• Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nat Rev Neurosci 2005;6:521-32
   PubMed Web of Science ®Google Scholar
• Vallejo R, Tilley DM, Vogel L, Benyamin R. The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Pract 2010;10(3):167-84
   PubMedGoogle Scholar
• Hutchinson MR, Shavit Y, Grace PM, Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacol Rev 2011;63:772-810
   PubMed Web of Science ®Google Scholar
• Gutierrez T, Nackley AG, Neely MH, Effects of neurotoxic destruction of descending noradrenergic pathways on cannabinoid antinociception in models of acute and tonic nociception. Brain Res 2003;987:176-85
   PubMed Web of Science ®Google Scholar
• Dogrul A, Seyrek M, Yalcin B, Ulugol A. Involvement of descending serotonergic and noradrenergic pathways in CB1 receptor-mediated antinociception. Prog Neuro Psychopharmacol Biol Psychiatry 2012; Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Philipp M, Brede M, Hein L. Physiological significance of α2-adrenergicc receptor subtype diversity: one receptor is not enough. Am J Physiol Regul Integr Comp Physiol 2002;283:R287-95
   PubMed Web of Science ®Google Scholar
• Sawamura S, Kingery WS, Davies MF, Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of α2B adrenoreceptors. J Neurosci 2000;20:9242-51
   PubMed Web of Science ®Google Scholar
• Adachi Y, Aleksic B, Ozaki N. Comparison of pharmacological profiles of serotonin norepinephrine reuptake inhibitors. Clin Neuropsychopharmacol Ther 2010;1:10-15
   Google Scholar
• Sadosky A, McDermott AM, Brandenburg NA, Strauss M. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Pract 2008;8(1):45-56
   PubMedGoogle Scholar
• Kopsky DJ, Keppel Hesselink JM. High doses of topical amitriptyline in neuropathic pain: two cases and literature review. Pain Pract 2012;12(2):148-53
   PubMed Web of Science ®Google Scholar
• Barton DL, Wos EJ, Qin R, A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer 2011;19(6):833-41
   PubMed Web of Science ®Google Scholar
• Uzaraga I, Gerbis B, Holwerda E, Topical amitriptyline, ketamine, and lidocaine in neuropathic pain caused by radiation skin reaction: a pilot study. Support Care Cancer 2012;20:1515-24
   PubMed Web of Science ®Google Scholar
• McCleane G. Pharmacological management of neuropathic pain. CNS Drugs 2003;17(14):1031-43
   PubMed Web of Science ®Google Scholar
• Elmariah SB, Lerner EA. Topical therapies for pruritus. Semin Cutan Med Surg 2011;30:118-26
   PubMed Web of Science ®Google Scholar
• Hartrick CT, Rozek RJ. Tapentadol in pain management: a μ-opioid receptor agonist and noradrenaline reuptake inhibitor. CNS Drugs 2011;25(5):359-70
   PubMed Web of Science ®Google Scholar
• Di Lorenzo L, Foti C, Forte AM, The addition of tramadol as a second opioid may improve pain relief in severe osteoarthritis: a prospective study. Pain Pract 2010;10(6):540-7
   PubMedGoogle Scholar
• Zegpi C, Gonzalez C, Pinardi G, Miranda HF. The effect of opioid antagonists on synergism between dexketoprofen and tramadol. Pharmacol Res 2009;60:291-5
   PubMed Web of Science ®Google Scholar
• Hartrick CT. Tapentadol immediate release for the relief of moderate-to-severe acute pain. Expert Opin Pharmacother 2009;10(16):2687-96
   PubMed Web of Science ®Google Scholar
• Hache G, Coudore F, Gardier AM, Guiard BP. Monoaminergic antidepressants in the relief of pain: potential therapeutic utility of Triple Reuptake Inhibitors (TRIs). Pharmaceuticals 2011;4:285-342
   Google Scholar
• Lucas MC, Weikert RJ, Carter DS, Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain. Bioorg Med Chem Lett 2010;20:5559-66
   PubMed Web of Science ®Google Scholar
• Bymaster FP, Golembiowska K, Kowalska M, Pharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB-1020: implications for treatment of attention-deficit hyperactivity disorder. Synapse 2012;66:522-32
   PubMed Web of Science ®Google Scholar
• Berger B, Adedoyin A, Marion A. Safety, tolerability, and pharmacokinetics of ADL6906, a novel dual norepinephrine reuptake inhibitor and serotonin receptor antagonist. J Pain 2011;12(4S):P54
   Google Scholar
• Lewis RJ, Dutertre S, Vetter I, Christie MJ. Conus venom peptide pharmacology. Pharmacol Rev 2012;64:259-98
   PubMed Web of Science ®Google Scholar
• Fedosova AE, Moshkovskiic SA, Kuznetsovac KG, Oliverab BM. Conotoxins: from the biodiversity of gastropods to new drug. Biomed Chem 2012;6(2):107-22
   Google Scholar
• Lewis RJ. Discovery and development of the χ-conopeptide class of analgesic peptides. Toxicon 2012;59:524-8
   PubMed Web of Science ®Google Scholar
• Tammimaki A, Mannisto PT. Catechol-O-methyltransferase gene polymorphism and chronic human pain: a systematic review and meta-analysis. Pharmacogenet Genomics 2012; [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Hartrick CT, Rodríguez Hernandez JR. Tapentadol for pain: a treatment evaluation. Expert Opin Pharmacother 2012;13(2):283-6
   PubMed Web of Science ®Google Scholar
• Hartrick CT, Gatchel RJ, Conroy S. Identification and management of pain medication abuse and misuse: current state and future directions. Expert Rev Neurother 2012;12(5):601-10
   PubMed Web of Science ®Google Scholar
• Yalcin I, Tessier L-H, Petit-Demoulière N, β2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain. Neurobiol Dis 2009;33:386-94
   PubMed Web of Science ®Google Scholar
• Zhao X, Xu Y, Zhao Q, Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: descending monoamine system and opioid receptors are differentially involved. Neuropharmacology 2012;62:843-54
   PubMed Web of Science ®Google Scholar